Latest Articles

Publication Date
Information Needs of Women Affected by Endometriosis and Their Environment: Qualitative Results from Participatory Workshops.

Background/Objectives: Endometriosis affects ~10% of women, causing chronic pain, reduced quality of life, and, often, infertility. As endometriosis literacy and awareness are low in society and among health care providers …

Published: Feb. 11, 2026, midnight
FBXW7 suppresses cell proliferation, migration, and epithelial-mesenchymal transition in endometrioid ovarian carcinoma.

Epithelial ovarian carcinoma is a common gynecologic malignancy. Evidence from several studies suggests that subtypes of this cancer-specifically clear-cell ovarian carcinoma and endometrioid ovarian carcinoma (ENOC)-are associated with endometriosis. FBXW7 …

Published: Feb. 11, 2026, midnight
The School Nurse Training Program Redefining Endometriosis Care for Students - Endometriosis Foundation of America

The School Nurse Training Program Redefining Endometriosis Care for Students Endometriosis Foundation of America

Published: Feb. 10, 2026, 10:33 p.m.
GLP-1 Receptor Agonists Combined with Progestins and Their Impact on - Bioengineer.org

GLP-1 Receptor Agonists Combined with Progestins and Their Impact on Bioengineer.org

Published: Feb. 10, 2026, 6:37 p.m.
GLP-1 Receptor Agonists Combined with Progestins and Their Impact on - BIOENGINEER.ORG

GLP-1 Receptor Agonists Combined with Progestins and Their Impact on BIOENGINEER.ORG

Published: Feb. 10, 2026, 6:37 p.m.
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment - IBTimes India

AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment IBTimes India

Published: Feb. 10, 2026, 11:57 a.m.
AstraZeneca Pharma India Receives CDSCO Approval for Imfinzi Cancer Treatment - scanx.trade

AstraZeneca Pharma India Receives CDSCO Approval for Imfinzi Cancer Treatment scanx.trade

Published: Feb. 10, 2026, 10:22 a.m.
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment - IANS LIVE

AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment IANS LIVE

Published: Feb. 10, 2026, 10:07 a.m.
AstraZeneca Shares Surge 3% on CDSCO Approval for Cancer Drug - Equitypandit

AstraZeneca Shares Surge 3% on CDSCO Approval for Cancer Drug Equitypandit

Published: Feb. 10, 2026, 9:36 a.m.
AstraZeneca Imfinzi Approved in India for Endometrial Cancer - Rediff MoneyWiz

AstraZeneca Imfinzi Approved in India for Endometrial Cancer Rediff MoneyWiz

Published: Feb. 10, 2026, 8:42 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!